Inogen Inc INGN
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2014-02-14 |
| Shares Out. | 27,070,000 |
| Website | inogen.com/ ↗ |
| Phone | 13026365400 |
| Employees | 753 |
| Revenue | $85.1M |
| Gross Profit | $37.9M |
| Net Income | -$8.3M |
| Free Cash Flow | -$2.4M |
| Total Assets | $285.9M |
| Total Liabilities | $103.0M |
| Equity | $182.9M |
About Inogen Inc
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
Inogen Inc is a publicly traded company under the ticker symbol INGN on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-07-01)